CFAP61-AS1

Across TCGA pan-cancer cohorts, CFAP61-AS1 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated CFAP61-AS1 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher CFAP61-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CFAP61-AS1 expression acts as an unfavorable survival marker, although some lineages such as LUAD and SKCM show a favorable association.

BLCA, COAD, and LIHC are the cancer types where CFAP61-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.424	0.554	.001	59	view →
COAD	DFS	Quartile	IV	0.329	0.578	<.001	43	view →
LIHC	DFS	Quartile	All	0.343	0.467	.003	42	view →
LUSC	DFS	Median	II,III,IV	0.268	0.499	<.001	42	view →
STAD	OS	Tertile	III,IV	0.207	0.669	<.001	30	view →
LUAD	DFS	Tertile	All	0.819	0.719	.004	28	view →
KICH	DFS	Tertile	All	0.580	0.932	.007	27	view →
UCEC	OS	Quartile	All	0.559	0.700	.017	12	view →
OV	OS	Tertile	II,III,IV	0.805	0.874	.015	12	view →
SKCM	OS	Median	All	0.910	0.832	.002	12	view →
BRCA	OS	Tertile	II,III,IV	0.437	0.565	.017	10	view →
GBM	DFS	Tertile	All	0.148	0.329	.005	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

CFAP61-AS1–BLCA (DFS)

Open the BLCA breakdown →